News

The myasthenia gravis treatment market is anticipated to grow at a CAGR of 7.14% from US$1.973 billion in 2025 to US$2.785 ...
Turbine’s virtual lab enables in silico experimentation using a vast library of cell models, patient-derived samples and virtual patients. By computationally predicting therapy effects, drug ...
Bayer Leverkusen CEO Fernando Carro has said ... but the fact is that we're a very professional club and we have to be prepared for anything," Carro told reporters on Monday.
'WE ARE HAPPT WITH HIM' Leverkusen CEO Fernando Carro told the Blick newspaper that the club has no plans to sell Xhaka. Expressing his satisfaction with the experienced midfielder’s ...
ConcertAI has announced an agreement that will allow Bayer to utilise its Translational360 and AI software-as-a-service (SaaS ...
Bayer Leverkusen's hopes of retaining their Bundesliga crown were dealt a huge blow following a 1-1 draw with St. Pauli on Sunday. (More Football News) Xabi Alonso's side are now eight points ...
Verified Market Research® a leading provider of business intelligence and market analysis is thrilled to announce the release of its comprehensive and authoritative report on the, "Contrast Media ...
According to NCDHHS, the detections were found in wastewater samples collected on March 25, March 28 and April 8 from a treatment plant in Greenville, NC. This year, there have been two cases of ...
Bruker Corporation today announced the launch of the Beacon Discovery™ Optofluidic System at the upcoming American ...
Bayer is preparing to start a phase 3 trial of its cell therapy candidate bemdaneprocel for Parkinson's disease after discussing phase 1 results with the FDA, while its experimental gene therapy ...